tranexamic acid

FDA Drug Profile — TRANEXAMIC ACID IN SODIUM CHLORIDE, tranexamic acid, Tranexamic Acid, TRANEXAMIC ACID, tranexamic acid in sodium chloride

tranexamic acid is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand names including TRANEXAMIC ACID IN SODIUM CHLORIDE, tranexamic acid, Tranexamic Acid. Available dosage forms: injection, solution, injection.

Drug Details

Generic Name
tranexamic acid
Brand Names
TRANEXAMIC ACID IN SODIUM CHLORIDE, tranexamic acid, Tranexamic Acid, TRANEXAMIC ACID, tranexamic acid in sodium chloride, Cyklokapron
Application Number
ANDA218242
Sponsor
Fresenius Kabi USA, LLC
NDC Codes
14
Dosage Forms
INJECTION, SOLUTION, INJECTION
Routes
INTRAVENOUS
Active Ingredients
TRANEXAMIC ACID

Indications and Usage

1 INDICATIONS AND USAGE Tranexamic acid injection is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. Tranexamic acid injection is an antifibrinolytic indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction. ( 1 )